[Experiences in therapy of aplastic anemias using oxymetholone].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000741:Anemia, Aplastic / Q000188:drug therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D004487:Edema / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010110:Oxymetholone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012156:Reticulocytes / Q000187:drug effects; D013997:Time Factors; D014770:Virilism / Q000139:chemically induced
D006454:Hemoglobins; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D010110:Oxymetholone
Die behandlung von aplastischen Anämien Erfahrungen mit Oxymetholon.